The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

International arbitration counsel for multinational consumer products corporation in major insurance recovery actions
The firm served as lead counsel in representing a major multinational corporation headquartered in Switzerland in two related international more
Acquisition of Dubai-based organization by Global Knowledge Training LLC
Advised Global Knowledge Training LLC, the largest privately held provider of training and enterprise learning services for information more
Design/build agreements for correctional facilities
Drafted and negotiated design/build agreements on behalf of P.J. Dick Incorporated for the construction of three campus-style correctional facilities more
Private equity advice for an i-gaming software development and system supply company
Represented a software development and system supply company in the i-gaming industry as sellers and the target company in connection with a private more